-
Hyperfine Inc. (HYPR) PT Raised to $2.50 at Lake Street
-
Hyperfine Inc. (HYPR) PT Raised to $1.60 at B.Riley
-
Hyperfine, Inc. (HYPR) Tops Q4 EPS by 2c
-
Hyperfine reports improved stroke detection with portable MRI system
-
Hyperfine reports portable MRI study shows 92% diagnostic concordance
-
Hyperfine enrolls first patient in contrast agent study for portable MRI
-
Hyperfine reports record Q4 revenue of $5.3 million, up 54% quarterly
-
Hyperfine reports cost savings from portable MRI system in hospital study
-
Hyperfine adds BTIG to $50 million stock offering program
-
Hyperfine receives regulatory approval for portable MRI system in India
-
Hyperfine receives FDA clearance for stroke detection software update
-
Hyperfine receives $3.7M Gates Foundation grant for brain imaging work
-
Hyperfine, Inc. (HYPR) Misses Q3 EPS by 3c, Misses on Revenue; Offers FY25 Revenue Guidance
-
Hyperfine starts enrolling patients in study of portable MRI in surgery
-
Hyperfine reports Q3 revenue of $3.4 million, up 27% sequentially
-
Hyperfine launches PULSE subscription platform for portable MRI research
-
Hyperfine, Inc. (HYPR) Reports In-Line Q2 EPS, Misses on Revenue; Offers Guidance
-
Hyperfine enrolls 100th patient in neurology office MRI study
-
Hyperfine enrolls first patients in emergency department MRI study
-
Hyperfine portable MRI shows 100% sensitivity for brain swelling detection
-
Hyperfine announces dementia studies using portable MRI system
-
Hyperfine launches Optive AI software for existing Swoop MRI systems
-
Hyperfine sells first commercial units of next-generation Swoop MRI system
-
Hyperfine (HYPR) Announces Executive Appointments
-
Hyperfine (HYPR) Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
-
Hyperfine (HYPR) announces FDA clearance of Optive AI software
-
Hyperfine, Inc. (HYPR) Reports In-Line Q1 EPS
-
Lake Street Capital Markets Starts Hyperfine Inc. (HYPR) at Buy
-
Hyperfine Inc. (HYPR) PT Raised to $1.20 at Jefferies
-
Hyperfine, Inc. (HYPR) Reports In-Line Q4 EPS
-
Hyperfine (HYPR) and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation
-
Hyperfine (HYPR) Announces 4.51M Share Offering at $1.33/sh
-
QuidelOrtho (QDEL) Announces Appointment of Two Independent Directors to its Board
-
Hyperfine, Inc. (HYPR) Reports In-Line Q3 EPS
-
Hyperfine (HYPR) Announces European Launch with CE Approval
-
Hyperfine (HYPR) Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality
-
Hyperfine (HYPR) Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care
-
Hyperfine (HYPR) Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain Images

